I read a recent review in Clinical Infectious Diseases (the second-ranked premier ID journal, depending on ranking criteria) on the World Health Organization’s (WHO’s) ranking of antibiotics a couple of days ago. The WHO has ranked antimicrobial agents according to their importance for human medicine since 2007, and has updated the list every 3 years or so. […]

Reading through several articles and reports on antimicrobial resistance, I came across a news story about a multidrug-resistant Pseudomonas outbreak linked to duodenoscopes at Huntington Memorial Hospital in the U.S.A. This is not the only outbreak linked to endoscopes this year – the more noteworthy event occurred at the Ronald Reagan UCLA Medical Centre, with 7 ill and 2 […]

The Society of Infectious Diseases (Singapore) has organised an annual infectious diseases clinical practice update for ID trainees and GPs/family medicine trainees for years. These practice updates are invariably organised by the trainees themselves, who have the liberty therefore to set the topics and invite the local consultants they would like to listen to. Somehow, I […]

The big news for antimicrobial resistance over the past week has been the decision by McDonald’s (the fast food chain) to use only antibiotic-free chicken in 2 years’ time. This will only affect the U.S. branches, although the company is also exploring phasing this in Europe. No signs of this happening in Singapore or the […]

A short summary of the current dilemma with antibiotic development. Others, including the World Health Organization and Infectious Diseases Society of America, have expressed this issue more elegantly and in greater detail (click on the links to check out), but it bears repeating: Drug discovery is tough. Discovering or creating a new (i.e. novel class of antibiotics) antibiotic […]

Shameless self-plug – but I had my first interview with Channel NewsAsia Live TV yesterday evening, on their “Between the Lines” program. It was on the novel antibiotic teixobactin and the iChip platform, and featured Dr Dallas Hughes (President of Novobiotic Pharmaceuticals LLC), as well as Prof Vinod K Paul (Head of Paediatrics at the […]

I have finally had the chance to read the Nature article (behind a pay wall) that has been making waves in the recent news, including the Guardian, Forbes and Bloomberg among others. The authors, who are from academic institutions in the USA (Boston) and Germany (Bonn), as well as a drug discovery company from the UK (Selcia, Ongar, […]

A new year has begun. What were the major infectious diseases events of the past year? The following two are my personal picks, reflecting on what I have read or experienced in 2014: Ebola outbreak in West Africa. This is the Ebola outbreak that dwarfs all previous outbreaks combined, and is still ongoing in Sierra […]

Antibiotic Awareness Day is today, and every 18th November. Started in 2008 by the European Centre for Disease Prevention and Control (ECDC), its aim is to highlight the importance of taking antibiotics responsibly and to end unnecessary use of antibiotics. Other countries such as United States, Australia and Canada have taken up this initiative, converting […]

http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70300-6/fulltext This open access article was published more than a year and a half ago in Lancet Infectious Diseases – one of the top journals for clinical infectious diseases research. 2,061 patients aged 18 years and older from 12 European countries were recruited when they presented to primary care (GP) practices for acute lower respiratory […]